Physician profile
Jeffrey D Morrison
NPI 1942281985
$27,270.21
in general payments reported to CMS, 2019-2025
32 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $8,266 · 2021: $7,956 · 2022: $198 · 2023: $346 · 2024: $10K · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $1,889 · Travel and Lodging: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $1,888.97 |
| Travel and Lodging | $732.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,214.19 | 2020-2024 | |
| Boston Scientific Corporation | $1,451.94 | 2020-2023 | Solyx Sis System |
| Coloplast Corp | $1,210.82 | 2019-2024 | |
| Abbvie INC. | $304.24 | 2019-2025 | |
| Astellas Pharma US INC | $179.54 | 2024-2025 | Veozah |
| Glaxosmithkline, LLC. | $137.03 | 2023 | Arexvy, Shingrix, Bexsero |
| Pfizer INC. | $97.40 | 2019-2025 | |
| Lilly USA, LLC | $80.78 | 2023-2024 | Mounjaro, Basaglar, Zepbound |
| Optumhealth Care Solutions, LLC | $73.71 | 2023 | Vivify Health Care Team Portal |
| Novo Nordisk INC | $58.34 | 2019-2025 | |
| Organon LLC | $49.13 | 2021-2022 | |
| Hologic Sales and Service, LLC | $40.65 | 2022-2023 | Aptima |
| Coopersurgical, INC. | $32.18 | 2019-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $31.82 | 2024-2025 | Myfembree |
| Medtronic, INC. | $27.32 | 2025 | Interstim |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $27.31 | 2022-2023 | |
| Aspira Women'S Health INC | $23.46 | 2022 | |
| Exeltis, USA INC. | $20.57 | 2021 | |
| Medtronic USA, INC. | $18.65 | 2020 | |
| Agile Therapeutics, INC. | $18.22 | 2021 | |
| Myovant Sciences INC. | $17.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.14 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.00 | 2019 | |
| Channel Medsystems, INC. | $15.18 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.55 | 2023 | Xarelto |
| Amag Pharmaceuticals, INC. | $14.36 | 2019 | |
| Therapeuticsmd, INC. | $14.27 | 2021 | |
| Momentis Surgical INC. | $13.92 | 2021 | |
| Merck Sharp & Dohme LLC | $13.48 | 2019 | |
| Shire North American Group INC | $12.25 | 2019 | |
| Smith+Nephew, INC. | $12.13 | 2019 | |
| Amgen INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.